journal.pmed.1003771 (1).pdf (215.1 kB)

ctDNA: An emerging neoadjuvant biomarker in resectable solid tumors.

journal contribution

posted on 20.10.2021, 10:12 by Christopher Abbosh, Charles Swanton

Christopher Abbosh and Charles Swanton discuss circulating tumor DNA as a potential biomarker for neoadjuvant treatment response in solid tumors.

Funding

Crick (Grant ID: 10169, Grant title: Swanton FC001169) Novo Nordisk UK Research Foundation (Grant ID: NNF15OC0016584, Grant title: NovoNordisk Foundation 16584) European Research Council (Grant ID: 835297 - PROTEUS, Grant title: ERC 835297 - PROTEUS)

History

Publisher DOI

https://doi.org/10.1371/journal.pmed.1003771

Usage metrics

The Francis Crick Institute

Categories

Keywords

Swanton FC001169 11 Medical and Health Sciences General & Internal Medicine

Licence

Exports